[1]
Muranov KO, Ostrovsky MA. Biochemistry of Eye Lens in the Norm and in Cataractogenesis. Biochemistry. Biokhimiia. 2022 Feb:87(2):106-120. doi: 10.1134/S0006297922020031. Epub
[PubMed PMID: 35508906]
[2]
Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Progress in biophysics and molecular biology. 2004 Nov:86(3):407-85
[PubMed PMID: 15302206]
[4]
Deepu S,Kujur ES,Horo S,Priyanka N,Selvin SST,Kuriakose T, Prescription of near addition and its relation to accommodative reserve in presbyopia - The dichotomy between theory and practice. Indian journal of ophthalmology. 2021 Jul;
[PubMed PMID: 34146010]
[5]
Iribarren R, Morgan IG, Nangia V, Jonas JB. Crystalline lens power and refractive error. Investigative ophthalmology & visual science. 2012 Feb 1:53(2):543-50. doi: 10.1167/iovs.11-8523. Epub 2012 Feb 1
[PubMed PMID: 22199240]
[6]
Cunha CC, Berezovsky A, Furtado JM, Ferraz NN, Fernandes AG, Muñoz S, Watanabe SS, Sacai PY, Cypel M, Mitsuhiro MH, Morales PH, Vasconcelos GC, Cohen MJ, Campos M, Cohen JM, Belfort R Jr, Salomão SR. Presbyopia and Ocular Conditions Causing Near Vision Impairment in Older Adults From the Brazilian Amazon Region. American journal of ophthalmology. 2018 Dec:196():72-81. doi: 10.1016/j.ajo.2018.08.012. Epub 2018 Aug 15
[PubMed PMID: 30118685]
[8]
Garner WH,Garner MH, Protein Disulfide Levels and Lens Elasticity Modulation: Applications for Presbyopia. Investigative ophthalmology
[PubMed PMID: 27233034]
[9]
David G, Pedrigi RM, Humphrey JD. Accommodation of the human lens capsule using a finite element model based on nonlinear regionally anisotropic biomembranes. Computer methods in biomechanics and biomedical engineering. 2017 Feb:20(3):302-307. doi: 10.1080/10255842.2016.1228907. Epub 2016 Sep 9
[PubMed PMID: 27609339]
[11]
Ruan X, Liu Z, Luo L, Liu Y. The Structure of the Lens and Its Associations with the Visual Quality. BMJ open ophthalmology. 2020:5(1):e000459. doi: 10.1136/bmjophth-2020-000459. Epub 2020 Sep 18
[PubMed PMID: 33024825]
Level 2 (mid-level) evidence
[12]
Cvekl A,McGreal R,Liu W, Lens Development and Crystallin Gene Expression. Progress in molecular biology and translational science. 2015;
[PubMed PMID: 26310154]
[13]
Dilmen G, Köktener A, Turhan NO, Tez S. Growth of the fetal lens and orbit. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2002 Mar:76(3):267-71
[PubMed PMID: 11880129]
[14]
Katz JA, Karpecki PM, Dorca A, Chiva-Razavi S, Floyd H, Barnes E, Wuttke M, Donnenfeld E. Presbyopia - A Review of Current Treatment Options and Emerging Therapies. Clinical ophthalmology (Auckland, N.Z.). 2021:15():2167-2178. doi: 10.2147/OPTH.S259011. Epub 2021 May 24
[PubMed PMID: 34079215]
[15]
Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Ho SM, Naduvilath T, Naidoo KS. Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling. Ophthalmology. 2018 Oct:125(10):1492-1499. doi: 10.1016/j.ophtha.2018.04.013. Epub 2018 May 9
[PubMed PMID: 29753495]
Level 1 (high-level) evidence
[16]
Patel I,Munoz B,Burke AG,Kayongoya A,McHiwa W,Schwarzwalder AW,West SK, Impact of presbyopia on quality of life in a rural African setting. Ophthalmology. 2006 May;
[PubMed PMID: 16650665]
Level 2 (mid-level) evidence
[17]
Reddy PA, Congdon N, MacKenzie G, Gogate P, Wen Q, Jan C, Clarke M, Kassalow J, Gudwin E, O'Neill C, Jin L, Tang J, Bassett K, Cherwek DH, Ali R. Effect of providing near glasses on productivity among rural Indian tea workers with presbyopia (PROSPER): a randomised trial. The Lancet. Global health. 2018 Sep:6(9):e1019-e1027. doi: 10.1016/S2214-109X(18)30329-2. Epub 2018 Jul 23
[PubMed PMID: 30049615]
Level 1 (high-level) evidence
[18]
Han X, Lee PY, Liu C, He M. Distribution and progression of add power among people in need of near correction. Clinical & experimental ophthalmology. 2018 Nov:46(8):882-887. doi: 10.1111/ceo.13301. Epub 2018 May 2
[PubMed PMID: 29663613]
[19]
Hickenbotham A, Roorda A, Steinmaus C, Glasser A. Meta-analysis of sex differences in presbyopia. Investigative ophthalmology & visual science. 2012 May 31:53(6):3215-20. doi: 10.1167/iovs.12-9791. Epub 2012 May 31
[PubMed PMID: 22531698]
Level 1 (high-level) evidence
[20]
Musa M, Aluyi-Osa G, Zeppieri M. Foster Kennedy Syndrome (FKS): A Case Report. Clinics and practice. 2022 Jul 12:12(4):527-532. doi: 10.3390/clinpract12040056. Epub 2022 Jul 12
[PubMed PMID: 35892442]
Level 3 (low-level) evidence
[22]
Tsui E, Patel P. Calculated Decisions: Visual acuity testing (Snellen chart). Emergency medicine practice. 2020 Apr 1:22(4):CD1-CD2
[PubMed PMID: 32259420]
[23]
Kalra S, Singh RR. Visual acuity assessment in diabetes. JPMA. The Journal of the Pakistan Medical Association. 2018 Sep:68(9):1407-1409
[PubMed PMID: 30317277]
[24]
Sánchez-González MC, García-Oliver R, Sánchez-González JM, Bautista-Llamas MJ, Jiménez-Rejano JJ, De-Hita-Cantalejo C. Minimum Detectable Change of Visual Acuity Measurements Using ETDRS Charts (Early Treatment Diabetic Retinopathy Study). International journal of environmental research and public health. 2021 Jul 25:18(15):. doi: 10.3390/ijerph18157876. Epub 2021 Jul 25
[PubMed PMID: 34360169]
[25]
Lupión Durán T, García-Ben A, Rodríguez Méndez V, Gálvez Alcázar L, García-Ben E, García-Campos JM. Study of visual acuity and contrast sensitivity in diabetic patients with and without non-proliferative diabetic retinopathy. International ophthalmology. 2021 Nov:41(11):3587-3592. doi: 10.1007/s10792-021-01930-x. Epub 2021 Jun 27
[PubMed PMID: 34176010]
[27]
Cordero I. Understanding and looking after a retinoscope and trial lens set. Community eye health. 2017:30(98):40-41
[PubMed PMID: 29070929]
Level 3 (low-level) evidence
[28]
Wubben TJ, Guerrero CM, Salum M, Wolfe GS, Giovannelli GP, Ramsey DJ. Presbyopia: a pilot investigation of the barriers and benefits of near visual acuity correction among a rural Filipino population. BMC ophthalmology. 2014 Jan 27:14():9. doi: 10.1186/1471-2415-14-9. Epub 2014 Jan 27
[PubMed PMID: 24467667]
Level 3 (low-level) evidence
[29]
Wubben T, Wolfe G, Guerrero C, Korcz WJ, Ramsey DJ. Near visual acuity in an inner city Hispanic community: understanding the barriers and benefits of correction. Community eye health. 2014:27(86):41-2
[PubMed PMID: 25316971]
Level 3 (low-level) evidence
[30]
Doan BD, Lévy D, Pavot J. [Demographic forecasts of medical workforce supply in France (2000-2050). What numerus clausus for what future?]. Cahiers de sociologie et de demographie medicales. 2004 Jan-Mar:44(1):101-48
[PubMed PMID: 15146660]
[31]
Goertz AD, Stewart WC, Burns WR, Stewart JA, Nelson LA. Review of the impact of presbyopia on quality of life in the developing and developed world. Acta ophthalmologica. 2014 Sep:92(6):497-500. doi: 10.1111/aos.12308. Epub 2013 Nov 13
[PubMed PMID: 24910300]
Level 2 (mid-level) evidence
[32]
Ma Q, Chen M, Li D, Zhou R, Du Y, Yin S, Chen B, Wang H, Jiang J, Guan Z, Qiu K. Potential productivity loss from uncorrected and under-corrected presbyopia in low- and middle-income countries: A life table modeling study. Frontiers in public health. 2022:10():983423. doi: 10.3389/fpubh.2022.983423. Epub 2022 Oct 11
[PubMed PMID: 36304252]
Level 2 (mid-level) evidence
[33]
Holden BA, Fricke TR, Ho SM, Wong R, Schlenther G, Cronjé S, Burnett A, Papas E, Naidoo KS, Frick KD. Global vision impairment due to uncorrected presbyopia. Archives of ophthalmology (Chicago, Ill. : 1960). 2008 Dec:126(12):1731-9. doi: 10.1001/archopht.126.12.1731. Epub
[PubMed PMID: 19064856]
[34]
Jaul E, Barron J. Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Frontiers in public health. 2017:5():335. doi: 10.3389/fpubh.2017.00335. Epub 2017 Dec 11
[PubMed PMID: 29312916]
[35]
Snider EL. Young-old versus old-old and the use of health services. Does the difference make a difference? Journal of the American Geriatrics Society. 1981 Aug:29(8):354-8
[PubMed PMID: 7264125]
[36]
Evans JR, Fletcher AE, Wormald RP, Ng ES, Stirling S, Smeeth L, Breeze E, Bulpitt CJ, Nunes M, Jones D, Tulloch A. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. The British journal of ophthalmology. 2002 Jul:86(7):795-800
[PubMed PMID: 12084753]
[37]
Budgell B. Guidelines to the writing of case studies. The Journal of the Canadian Chiropractic Association. 2008 Dec:52(4):199-204
[PubMed PMID: 19066690]
Level 3 (low-level) evidence
[39]
Grzybowski A, Ruamviboonsuk V. Pharmacological Treatment in Presbyopia. Journal of clinical medicine. 2022 Mar 3:11(5):. doi: 10.3390/jcm11051385. Epub 2022 Mar 3
[PubMed PMID: 35268476]
[40]
Levinger E, Trivizki O, Pokroy R, Levartovsky S, Sholohov G, Levinger S. Monovision surgery in myopic presbyopes: visual function and satisfaction. Optometry and vision science : official publication of the American Academy of Optometry. 2013 Oct:90(10):1092-7. doi: 10.1097/OPX.0000000000000002. Epub
[PubMed PMID: 24064524]
[41]
Kanclerz P, Toto F, Grzybowski A, Alio JL. Extended Depth-of-Field Intraocular Lenses: An Update. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2020 May-Jun:9(3):194-202. doi: 10.1097/APO.0000000000000296. Epub
[PubMed PMID: 32511121]
[43]
Musa MJ, Zeppieri M. Principles And Technique Of Fogging During Subjective Refraction. StatPearls. 2023 Jan:():
[PubMed PMID: 36251830]
[44]
Blystone PA. Relationship between age and presbyopic addition using a sample of 3,645 examinations from a single private practice. Journal of the American Optometric Association. 1999 Aug:70(8):505-8
[PubMed PMID: 10506813]
[45]
Crooke A, Martínez-Alberquilla I, Madrid-Costa D, Ruiz-Alcocer J. Presbyopia: An outstanding and global opportunity for early detection of pre-frailty and frailty states. Frontiers in medicine. 2022:9():968262. doi: 10.3389/fmed.2022.968262. Epub 2022 Oct 4
[PubMed PMID: 36267611]